UK launches new daily diabetes pill for weight loss

A new weight-loss and diabetes medication, Foundayo, developed by Eli Lilly, is now available in UK pharmacies through private prescriptions. Approved by the MHRA, it is the first oral GLP-1 treatment in Europe and targets individuals with a BMI of 30 or higher, or those with BMI between 27 and 30 with related conditions. Pharmacists have expressed optimism about expanding treatment options but warned about the increasing risk of counterfeit drugs.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل